How to identify and manage diabetes mellitus after renal transplantation

Journal of Renal Care
Kathryn K StevensAlan G Jardine

Abstract

New-onset diabetes after transplantation (NODAT) has serious consequences for the patient in terms of overall survival, graft function and graft survival. The incidence of NODAT and impaired glucose tolerance has probably been underestimated previously because of lack of a universal diagnostic definition. Many risk factors have been identified, a proportion of which are modifiable. Early identification of those who are at high risk of NODAT and strategies to reduce risk will help to reduce the morbidity and mortality resulting from this condition. Where prevention is not possible, stringent management strategies are essential. Although, this article focuses on NODAT in the renal transplant recipient and considers the scale of the problem, impact on patient and transplant survival, determinants and risk factors for, and the management of, impaired glucose tolerance and NODAT, much of it will also be applicable to other types of solid organ transplantation.

References

Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R N FoleyM J Sarnak
Mar 29, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J HjelmesaethP Fauchald
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S H MehtaD L Thomas
Mar 5, 2002·Diabetes Care·Victor M MontoriYogish C Kudva
Jul 12, 2002·Kidney International·Arthur J MatasDavid E R Sutherland
Dec 28, 2002·Diabetes Care·UNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Feb 27, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Bertram L KasiskeArthur J Matas
Apr 30, 2003·Transplantation·Herwig-Ulf Meier-KriescheBruce Kaplan
Jun 20, 2003·Lancet·Hallvard HoldaasUNKNOWN Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Nassim KamarLionel Rostaing
Jun 12, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jose Manuel González-PosadaManuel Rivero Sanchez
Dec 8, 2004·Journal of the American Society of Nephrology : JASN·Karsten MidtvedtTrond Jenssen
Dec 24, 2004·Journal of the American Society of Nephrology : JASN·Krista L LentineMark A Schnitzler
May 10, 2005·Clinical Transplantation·Alan WilkinsonMartin Wissing
Jul 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jøran HjelmesaethAnders Hartmann
Sep 16, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Fabrizio FabriziGareth Dulai
Feb 17, 2007·Clinical Transplantation·Nicola JossAlan G Jardine
Mar 16, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·F VincentiN Goto
Feb 26, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·F G CosioY Kudva
Feb 28, 2008·Transplantation·Arthur J MatasRaja Kandaswamy
Mar 7, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Edward H ColeJohn S Gill
Apr 4, 2008·Journal of the American Society of Nephrology : JASN·Olwyn JohnstonJohn S Gill
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jul 22, 2008·Advances in Therapy·John Doupis, Aristidis Veves
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Jan 8, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yasuji AraseHiromitsu Kumada
Apr 10, 2009·Journal of the American Society of Nephrology : JASN·Sylvia P B RamirezFriedrich K Port
Jun 10, 2009·Circulation·Thomas H MarwickUNKNOWN Interdisciplinary Council on Quality of Care and Outcomes Research
Oct 23, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons

❮ Previous
Next ❯

Citations

Apr 26, 2015·Expert Opinion on Pharmacotherapy·María José Pérez-SáezJulio Pascual

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Phuong-Thu T PhamPhuong-Chi T Pham
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
C J YatesS J Cohney
© 2022 Meta ULC. All rights reserved